ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas

Surgery

Volumn 146, Issue 2, 2009, Pages 213-219

  Arrington, Amanda K ^a   Dahlberg, Peter S ^a   Davydova, Julia ^a   Vickers, Selwyn M ^a   Yamamoto, Masato ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ESOPHAGUS CANCER; GASTROINTESTINAL CARCINOMA; GENE AMPLIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CANCER;

ADENOCARCINOMA; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; GENE AMPLIFICATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 67650523227     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.04.008     Document Type: Article

References (19)

1. Phillips C. Spotlight: the curious rise of esophageal adenocarcinoma. NCI Cancer Bulletin (2008). http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_051606/page4 Accessed June 18, 2009
2. ® cancer information summaries: prevention. NCI Topics Page. National Cancer Institute Web site. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/esophageal/HealthProfessional/page2. Accessed on June 18, 2009.
3. Devesa S.S., Blot W.J., and Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
4. Metzger R., Schneider P.M., Warnecke-Eberz U., et al. Molecular biology of esophageal cancer. Onkologie 27 (2004) 200-206
5. Lin J., and Beer D. Molecular biology of upper gastrointestinal malignancies. Semin Oncol 31 (2004) 476-486
6. Dahlberg P.S., Ferrin L.F., Grindle S.M., et al. Gene expression profiles in esophageal adenocarcinoma. Ann Thorac Surg 77 (2004) 1008-1015
7. Kuwano H., Kato H., Miyazaki T., et al. Genetic alterations in esophageal cancer. Surg Today 35 (2005) 7-18
8. Miller C.T., Moy J.R., Lin L., et al. Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia. Clin Cancer Res 9 (2003) 4819-4825
9. Jenkins G.J., Doak S.H., Parry J.M., et al. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br J Surg 89 (2002) 824-837
10. Chiang P.W., Beer D.G., Wei W.L., et al. Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. Clin Cancer Res 5 (1999) 1381-1386
11. Park J.B., Rhim J.S., Park S.C., et al. Amplification, overexpression, and rearrangement of erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res 49 (1989) 6605-6609
12. Tanner M., Hollmen M., Junttila T.T., et al. Amplification of Her-2 in gastric carcinoma: association with topoisomerase II-α gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Onc 16 (2006) 273-278
13. Holbro T., Civenni G., and Hynes N.E. The ErbB receptors and their role in cancer progression. Exp Cell Res 284 (2003) 99-110
14. Slamon D.J., Godolphin W., Jones L.A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
15. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25 (2007) 118-145
16. Arteaga C.L., and Baselga J. Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?. Cancer Cell 5 (2004) 525-531
17. Casimiro M., Rodriguez O., Pootrakul L., et al. ErB-2 induces the cyclin-D1 gene in prostate epithelial cells in vitro and in vivo. Cancer Res 67 (2007) 4364-4372
18. Safran H., Steinhoff M., Mangray S., et al. Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. Am J Clin Oncol 24 (2001) 496-499
19. Hirsch F.R., Franklin W.A., Veve R., et al. HER2/neu expression in malignant lung tumors. Semin Oncol 2929 1 Suppl 4 (2002) 51-58